Quercetin: A flavonoid with the potential to treat asthma

Brazilian Journal of Pharmaceutical Sciences

Volumn 48, Issue 4, 2012, Pages 589-599

  Fortunato, Laila Rigolin ^a   Alves, Claudiney de Freitas ^a   Teixeira, Maxelle Martins ^a   Rogerio, Alexandre Paula ^a  

^a Laboratory of Experimental Immunopharmacology   (Brazil)

Author keywords

Asthma; Flavonoids; Quercetin

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; COLLAGEN TYPE 3; CORTICOSTEROID; GINKGO BILOBA EXTRACT; HYPERICUM PERFORATUM EXTRACT; IMMUNOGLOBULIN E; ISOQUERCITRIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PRANLUKAST; QUERCETIN; SALBUTAMOL; ZAFIRLUKAST; ZILEUTON;

AIRWAY REMODELING; ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; CARDIOVASCULAR DISEASE; COLLAGEN SYNTHESIS; CORTICOSTEROID INDUCED OSTEOPOROSIS; CUSHING SYNDROME; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DRUG ABSORPTION; DRUG INDUCED HEADACHE; DRUG STRUCTURE; EOSINOPHILIA; GASTROINTESTINAL SYMPTOM; HEART RATE; HISTAMINE RELEASE; HUMAN; LIVER FIBROSIS; MAST CELL DEGRANULATION; MENTAL DISEASE; MICROEMULSION; MUCUS SECRETION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHYTOTHERAPY; POTASSIUM BLOOD LEVEL; REVIEW; SIDE EFFECT; SUSPENSION;

EID: 84874285811     PISSN: 19848250     EISSN: 21759790     Source Type: Journal    
DOI: 10.1590/S1984-82502012000400002     Document Type: Review

References (92)

1. BAOWEN, Q.; YULIN, Z.; XIN, W.; WENJING, X.; HAO, Z.; ZHIZHI, C.; XINGMEI, D.; XIA, Z.; YUQUAN, W.; LIJUAN, C. A further investigation concerning correlation between anti-fibrotic effect of liposomal quercetin and inflammatory cytokines in pulmonary fibrosis. Eur. J. Pharmacol., v.642, n.1-3, p.134-139, 2010.
2. BARNES, P.J. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci., v.94, n.6, p.557-572, 1998.
3. BARNES, P.J. How corticosteroids control inflammation: quintiles prize lecture 2005. Br. J. Pharmacol., v.148, n.3, p.245-254, 2006.
4. BARNES, P.J. Pathophysiology of allergic inflammation. Immunol. Rev., v.242, n.1, p.31-50, 2011.
5. BELLEGUIC, C.; CORBEL, M.; GERMAIN, N.; LÉNA, H.; BOICHOT, E.; DELAVAL, P.H.; LAGENTE, V. Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients. Clin. Exp. Allergy, v.32, n.2, p.217-223, 2002.
6. BÉRAUD, C.; HENZEL, W.J.; BAEUERLE, P.A. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappa B activation. Proc. Natl. Acad. Sci. USA, v.96, n.2, p.429-434, 1999.
7. BOUSQUET, J.; JEFFERY, P.K.; BUSSE, W.W.; JOHNSON, M.; VIGNOLA, A.M. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med., v.161, n.5, p.1720-1745, 2000.
8. BOUSQUET, J.; YSSEL, H.; VIGNOLA, A.M. Is allergic asthma associated with delayed fetal maturation or the persistence of conserved fetal genes? Allergy, v.55, n.12, p.1194-1197, 2000.
9. CALIXTO, J.B.; BEIRITH, A.; FERREIRA, J.; SANTOS, A.R.; FILHO, V.C.; YUNES, R.A. Naturally occurring antinociceptive substances from plants. Phytother. Res., v.14, n.6, p.401-418, 2000.
10. CALIXTO, J.B.; CAMPOS, M.M.; OTUKI, M.F.; SANTOS, A.R. Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med., v.69, n.2, p.973-983, 2004.
11. CANNING, S.; WATERMAN, M.; ORSI, N.; AYRES, J.; SIMPSON, N.; DYE, L. The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial. CNS Drugs, v.24, n.3, p.207-225, 2010.
12. CAZZOLA, M.; MATERA, M.G.; DONNER, C.F. Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease. Drugs, v.65, n.12, p.1595-1610, 2005.
13. CHANG, J.H.; SONG, K.J.; KIM, H.J.; KIM, J.H.; KIM, N.H.; KIM, K.S. Dietary polyphenols affect MUC5AC expression and ciliary movement in respiratory cells and nasal mucosa. Am. J. Rhinol. Allergy, v.24, n.2, p.59-62, 2010.
14. CHUA, F.; LAI, D. Acute severe asthma: Triage, treatment and thereafter current. Current Anaesthesia & Critical Care, v.18, n.2, p.61-68, 2007.
15. CLUTTERBUCK, E.J.; SANDERSON, C.J. Human eosinophil hematopoiesis studied in vitro by means of murine eosinophil differentiation factor [IL5]: production of functionally active eosinophils from normal human bone marrow. Blood, v.71, n.3, p.646-651, 1988.
16. CRUZ, E.A.; REUTER, S.; MARTIN, H.; DEHZAD, N.; MUZITANO, M.F.; COSTA, S.S.; ROSSI-BERGMANN, B.; STASSEN, M.; TAUBE, C. Kalanchoe pinnata inhibits mast cell activation and prevents allergic airway disease. Phytomed., v.19, n.2, p.115-121, 2012.
17. DE BOER, V.C.; DIHAL, A.A.; VAN DER WOUDE, H.; ARTS, I.C.; WOLFFRAM, G.M.; ALINK, G.M.; RIETJENS, I.M.; KEIJER, J.; HOLLMAN, P.C. Tissue distribution of quercetin in rats and pigs. J. Nutr., v.135, n.7, p.1718-1725, 2005.
18. DIAS, R.P.; KUMARAN, A.; CHAN, L.F.; MARTIN, L.; AFSHAR, F.; MATSON, M.; PLOWMAN, P.N.; MONSON, J. P; BESSER, G.M.; GROSSMAN, A.B.; SAVAGE, M.O.; STORR, H.L. Diagnosis, management and therapeutic outcome in prepubertal Cushing's disease. Eur. J. Endocrinol., v.162, p.603-609, 2010.
19. EGERT, S.; BOESCH-SAADATMANDI, C.; WOLFFRAM, S.; RIMBACH, G.; MULLER M.J. Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein e genotype. J. Nutr., v.140, n.2, p.278-284, 2010.
20. FACCIOLI, L.H.; MOKWA, V.F.; SILVA C.L.; ROCHA, G.M.; ARAUJO, J.I.; NAHORI, M.A.; VARGAFTIG, B.B. IL-5 drives eosinophils from bone marrow to blood and tissues in a guinea-pig model of visceral larva migrans syndrome. Mediators Inflamm., v.5, n.1, p.24-31, 1996.
21. FLOWER, R.J. Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids. Br. J. Pharmacol., v.94, n.4, p.987-1015, 1988.
22. FORMARIZ, T.P.; CHIAVACCI, L.A.; SARMENTO, V.H.V.; SANTILLI, C.V.; TABOSA DO EGITO, E.S.; OLIVEIRA, A.G. Relationship between structural features and in vitro release of doxorubicin from biocompatible anionic microemulsion. Colloids Surf. B Biointerface, v.60, n.1, p.28-35, 2007.
23. FURUICHI, K.; RIVERA, J.; ISERSKY, C. The receptor for immunoglobulin E on rat basophilic leukemia cells: Effect of ligand binding on receptor expression. Proc. Natl. Acad. Sci. USA, v.82, n.5, p.1522-1525, 1985.
24. GANESAN, S.; FARIS, A.N.; COMSTOCK, A.T.; CHATTORAJ, S.S.; CHATTORAJ, A.; BURGESS, J.R.; CURTIS, J.L.; MARTINEZ, F.J.; ZICK, S.; HERSHENSON, M.B.; SAJJAN, U.S. Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression. Respir. Res., v.11, n.1, p.131-146, 2010.
25. GLEICH, G.J.; LOEGERING, D.A. Immunobiology of eosinophils. Annu. Rev. Immunol., v.2, p.429-445, 1984.
26. GOULD, H.J.; SUTTON, B.J. IgE in allergy and asthma today. Nat. Rev. Immunol, v.8, n.3, p.205-217, 2008.
27. GUPTA, S.; MOULIK, S.P.; LALA, S.; BASU, M.K.; SANYAL, S.K.; DATTA, S. Designing and testing of an effective oil-in-water microemulsion drug delivery system for in vivo application. Drug Deliv., v.12, n.5, p.267-273, 2005.
28. HARRIS, L. Comparison of the effect on blood gases, ventilation, and perfusion of isoproterenol-phenylephrine and salbutamol aerosols in chronic bronchitis with asthma. J. Allergy Clin. Immunol., v.49, n.2, p.63-71, 1972.
29. HARWOOD, M.; DANIELEWSKA-NIKIEL, B.; BORZELLECA, J.F.; FLAMM, G.W.; WILLIAMS, G.M.; LINES, T.C. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem. Toxicol., v.45, n.11, p.2179-2205, 2007.
30. HOLGATE, S.T.; POLOSA, R. Treatment strategies for allergy and asthma. Nat. Rev. Immunol., v.8, n.3, p.218-230, 2008.
31. HOLLMAN, P.C.; DE VRIES, J.H.; VAN LEEUWEN, S.D.; MENGELERS, M.J.; KATAN, M.B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr., v.62, n.6, p.1276-1282, 1995.
32. HOLLMAN, P.C.; VAN TRIJP, J.M.; BUYSMAN, M.N.; VAN DER GAAG, M.S.; MENGELERS, M.J.; DE VRIES, J.H.; KATAN, M.B. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett., v.418, n.1-2, p.152-156, 1997.
33. JIANG, J.S.; CHIEN, H.C.; CHEN, C.M.; LIN, C.N.; KO, W.C. Potent suppressive effects of 3-O-methylquercetin 5,7,3',4'-O-tetraacetate on ovalbumin-induced airway hyperresponsiveness. Planta Med., v.73, n.11, p.1156-1162, 2007.
34. JOSE, P.J.; GRIFFITHS-JOHNSON, D.A.; COLLINS, P.D.; WALSH, D.T.; MOQBEL, R.; TOTTY, N.F.; TRUONG, O.; HSUAN, J.J.; WILLIAMS, T.J. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med., v.179, n.3, p.881-887, 1994.
35. JOSKOVA, M.; FRANOVA, S.; SADLONOVA, V. Acute bronchodilator effect of quercetin in experimental allergic asthma. Bratisl. Lek. Listy, v.112, n.1, p.9-12, 2011.
36. JUNG, C.H.; LEE, J.Y.; CHO, C.H.; KIM, C.J. Anti-asthmatic action of quercetin and rutin in conscious guinea-pigs challenged with aerosolized ovalbumin. Arch. Pharm. Res., v.30, n.12, p.1599-1607, 2007.
37. KEMPURAJ, D.; MADHAPPAN, B.; CHRISTODOULOU, S.; BOUCHER, W.; CAO, J.; PAPADOPOULOU, N.; CETRULO, C.L.; THEOHARIDES T.C. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br. J. Pharmacol., v.145, n.7, p.934-944, 2005.
38. KNEKT, P.; KUMPULAINEN, J.; JÄRVINEN, R.; RISSANEN, H.; HELIÖVAARA, M.; REUNANEN, A.; HAKULINEN, T.; AROMAA, A. Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr., v.76, n.3, p.560-568, 2002.
39. KO, W.C.; SHIH, C.M.; CHEN, M.C.; LAI, Y.H.; CHEN, J.H.; CHEN, C.M.; LIN, C.N. Suppressive effects of 3-O-methylquercetin on ovalbumin-induced airway hyperresponsiveness. Planta Med., v.70, n.12, p.1123-1127, 2004.
40. LAZAREVIC, V.; GLIMCHER, L.H. T-bet in disease. Nat. Immunol., v.12, n.7, p.597-606, 2011.
41. LLOYD, C.M.; HESSEL, E.M. Functions of T cells in asthma: more than just Th2 cells. Nat. Rev. Immunol., v.10, n.12, p.838-848, 2010.
42. LONG, X.; ZENG, X.; ZHANG, F.Q.; WANG, X.J. Influence of quercetin and x-ray on collagen synthesis of cultured human keloid-derived fibroblasts. Chin. Med. Sci. J., v.21, n.3, p.179-183, 2006.
43. MACFARLANE, D.P.; FORBES, S.; WALKER, B.R. Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome. J. Endocrinol., v.197, n.2, p.189-204, 2008.
44. MADRID, L.V.; MAYO, M.W.; REUTHER, J.Y.; BALDWIN JR, A.S. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-kappa B through utilization of the I kappa B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem., v.276, n.22, p.18934-18940, 2001.
45. MESSER, J.; PETERS, G.A.; BENNET, W.A. Cause of death and pathological findings in 304 cases of bronchial asthma. Chest, v.38, p.616-624, 1960.
46. MIDDLETON, E.; CHITHAN, K.; THEOHARIDES, T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev., v.52, n.4, p.673-751, 2000.
47. MIN, Y.D.; CHOI, C.H.; BARK, H.; SON, H.Y.; PARK, H.H.; LEE, S.; PARK, J.W.; PARK, E.K.; SHIN, H.I.; KIM, S.H. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflamm. Res., v.56, n.5, p.210-215, 2007.
48. MONTUSCHI, P.; SALA, A.; DAHLEN, S.E.; FOLCO, G. Pharmacological modulation of the leukotriene pathway in allergic airway disease. Drug Discov. Today, v.12, n.9-10, p.404-412, 2007.
49. MOON, H.; CHOI, H.H.; LEE, J.Y.; MOON, H.J.; SIM, S.S.; KIM, C.J. Quercetin inhalation inhibits the asthmatic responses by exposure to aerosolized-ovalbumin in conscious guinea-pigs. Arch. Pharm. Res., v.31, n.6, p.771-778, 2008.
50. MUKHERJEE, A.B.; ZHANG, Z. Allergic Asthma: Influence of Genetic and Environmental Factors. J. Biol. Chem., v.286, n.38, p.32883-32889, 2011.
51. NAKAMURA, T.; MATSUSHIMA, M.; HAYASHI, Y.; SHIBASAKI, M.; IMAIZUMI, K.; HASHIMOTO, N.; SHIMOKATA. K.; HASEGAWA, Y.; KAWABE, T. Attenuation of transforming growth factor-β-stimulated collagen production in fibroblasts by quercetin-induced heme oxygenase-1. Am. J. Respir. Cell. Mol. Biol., v.44, n.5, p.614-620, 2011.
52. NAM, N.H. Naturally occurring NF-kappa B inhibitors. Mini Rev. Med. Chem., v.6, n.8, p.945-951, 2006.
53. NANUA, S.; ZICK, S.M.; ANDRADE, J.E.; SAJJAN, U.S.; BURGESS, J.R.; LUKACS, N.W.; HERSHENSON, M.B. Quercetin blocks airway epithelial cell chemokine expression. Am. J. Respir. Cell. Mol. Biol., v.35, n.5, p.602-610, 2006.
54. NATIONAL INSTITUTES OF HEALTH. NIH. National Heart and Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma. Expert Panel Report 2. Bethesda, 1997. (NIH Publication, no.9740-51). 134 p.
55. OKAMOTO, T. Safety of quercetin for clinical application (Review). Int. J. Mol. Med., v.16, n.2, p.275-278, 2005.
56. PAPIRIS, S.A.; MANALI, E.D.; KOLILEKAS, L.; TRIANTAFILLIDOU, C.; TSANGARIS, I. Acute severe asthma: new approaches to assessment and treatment. Drugs, v.69, n.17, p.2363-2391, 2009.
57. PARK, H.H.; LEE, S.; SON, H.Y.; PARK, S.B.; KIM, E.J.; CHOI, T.S.; SINGH, J.H.; HA, M.G.; LEE, J.E.; KIM, M.C.; HYUN, T.K.; KWON, Y.H.; KIM, S.H. Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Arch. Pharm. Res., v.31, n.10, p.1303-1311, 2008.
58. PARK, H.J.; LEE, C.M.; JUNG, I.D.; LEE J.S.; JEONG, Y.I.; CHANG, J.H.; CHUN, S.H.; KIM, M.J.; CHOI, I.W.; AHN, S.C.; SHIN, Y.K.; YEOM, S.R.; PARK, Y.M. Quercetin regulates Th1/Th2 balance in a murine model of asthma. Int. Immunopharmacol., v.9, n.3, p.261-267, 2009.
59. PEREZ-VIZCAINO, F.; DUARTE, J.; JIMENEZ, R.; SANTOS-BUELGA, C.; OSUNA, A. Antihypertensive effects of the flavonoid quercetin. Pharmacol. Rep., v.61, n.1, p.67-75, 2009.
60. PERRETTI, M.; FLOWER, R.J. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin1. J. Immunol., v.150, n.3, p.992-999, 1993.
61. PETERS-GOLDEN, M.; HENDERSON JR, W.R. Leukotrienes. N. Engl. J. Med., v.357, n.18, p.1841-1854, 2007.
62. PIETTA, P.G. Flavonoids as antioxidants-review. J. Nat. Prod., v.63, n.7, p.1035-1042, 2000.
63. POTTERAT, O.; HAMBURGER, M. Drug discovery and development with plant-derived compounds. Prog. Drug Res., v.65, n.45, p.47-118, 2008.
64. QI, L.H.; KANG, L.P.; ZHANG, J.P.; SHI, N.; ZHANG, M.; WU, T.M. Antifibrotic effects of genistein and quercetin in vitro. Yao Xue Xue Bao, v.36, n.9, p.648-651, 2001.
65. RABIER, M.; DAMON, M.; CHANEZ, P.; MENCIA HUERTA, J.M.; BRAQUET, P.; BOUSQUET, J.; MICHEL, F.B.; GODARD, P. Neutrophil chemotactic activity of PAF, histamine, and neuromediators in bronchial asthma. J. Lipid Mediator., v.4, n.3, p.265-275, 1991.
66. RAHMAN, I.; ADCOCK, I.M. Oxidative stress and redox regulation of lung inflammation in COPD. Eur. Respir. J., v.28, n.1, p.219-242, 2006.
67. st century. Subcell Biochem., v.42, p.3-27, 2007.
68. ROGERIO, A.P.; DORA, C.L.; ANDRADE, E.L.; CHAVES, J.S.; SILVA, L.F.; LEMOS-SENNA, E.; CALIXTO, J.B. Anti-inflammatory effect of quercetin-loaded microemulsion in the airways allergic inflammatory model in mice. Pharmacol. Res., v.61, n.4, p.288-297, 2010.
69. ROGERIO, A.P.; KANASHIRO, A.; FONTANARI, C.; DA SILVA, E.V.; LUCISANO-VALIM, Y.M.; SOARES, E.G.; FACIOLI, L.H. Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma. Inflamm. Res., v.56, n.10, p.402-408, 2007.
70. ROGERIO, A.P.; SÁ-NUNES, A.; FACCIOLI, L.H. The activity of medicinal plants and secondary metabolites on eosinophilic inflammation. Pharmacol. Res., v.62, n.4, p.298-307, 2010.
71. ROMAGNANI, S. Cytokines and chemoattractants in allergic inflammation. Mol. Immunol., v.38, n.12-13, p.881-885, 2002.
72. ROTHENBERG, M.E.; HOGAN, S.P. The eosinophil. Annu. Rev. Immunol., v.24, p.147-174, 2006.
73. ROTHENBERG, M.E.; LUSTER, A.D.; LILLY, C.M.; DRAZEN, J.M.; LEDER, P. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J Exp. Med., v.181, n.3, p.1211-1216, 1995.
74. SAGGINI, A.; MACCAURO, G.; TRIPODI, D.; DE LUTIIS, M.A.; CONTI, F.; FELACO, P.; FULCHERI, M.; GALZIO, R.; CARAFFA, A.; ANTINOLFI, P.; FELACO, M.; PANDOLFI, F.; SABATINO, G.; NERI, G.; SHAIK-DASTHAGIRISAHEB. Y.B. Allergic inflammation: role of cytokines with special emphasis on IL-4. Int. J. Immunopathol. Pharmacol., v.24, n.2, p.305-311, 2011.
75. SALVI, S.S.; KRISHNA, M.T.; SAMPSON, A.P.; HOLGATE, S.T. The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma. Chest, v.119, n.5, p.1533-1546, 2001.
76. SALPETER, S.R.; ORMISTON, T.M.; SALPETER, E.E. Cardiovascular effects of beta agonists in patients with asthma and COPD: a meta-analysis. Chest, v.125, n.6, p.2309-2321, 2004.
77. SANDERSON, C.J.; WARREN, D.J.; STRATH, M. Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures. J. Exp. Med., v.162, n.1, p.60-74, 1985.
78. SNEADER, W. Drug discovery: a history. West Sussex: John Wiley and Sons, 2005. 472 p.
79. STANCIU, L.A.; DJUKANOVIC, R. The role of ICAM-1 on T-cells in the pathogenesis of asthma. Eur. Respir. J., v.11, n.4, p.949-957, 1998.
80. SUR, S.; CROTTY, T.B.; KEPHART, G.M.; HYMA, B.A.; COLBY, T.V.; REED, C.E.; HUNT, L.W.; GLEICH, G.J. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am. Rev. Respir. Dis., v.148, n.3, p.713-719, 1993.
81. TILLIE-LEBLOND, I.; GOSSET, P.; TONNEL, A.B. Inflammatory events in severe acute asthma. Allergy, v.60, n.1, p.23-29, 2005.
82. VERPOORTE, R. Exploration of nature's chemodiversity: the role of secondary metabolites as leads in drug development. Drug Discovery Today, v.3, n.5, p.232-238, 1999.
83. VICENTINI, F.T.M.C.; SIMI, T.R.; DEL CIAMPO, J.O.; WOLGA, N.O.; PITOL, D.L.; IYOMASA, M.M.; BENTLEY, M.V.; FONSECA, M.J. Quercetin in w/o microemulsion: In vitro and in vivo skin penetration and efficacy against UVB-induced skin damages evaluated in vivo. Eur. J. Pharm. Biopharm., v.69, n.3, p.948-957, 2008.
84. WADSWORTH, T.L.; MCDONALD, T.L.; KOOP, D.R. Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-α. Biochem. Pharmacol., v.62, n.7, p.963-974, 2001.
85. WALLE, T.; WALLE, U.K.; HALUSHKA, P.V. Carbon dioxide is the major metabolite of quercetin in humans. J. Nutr., v.131, n.10, p.2648-2652, 2001.
86. WANG, Y.H.; CHAO, P.D.; HSIU, S.L.; WEN, K.C.; HOU, Y.C. Lethal quercetin-digoxin interaction in pigs. Life Sci., v.74, n.10, p.1191-1197, 2004.
87. WENZEL, S.E. Asthma: defining of the persistent adult phenotypes. Lancet, v.386, n.9537, p.804-813, 2006.
88. WORT, S.J. The management of acute severe asthma in adults. Current Anaesthesia & Critical Care, v.14, n.2, p.81-89, 2003.
89. XU, B.; HE, S.S.; HAN, C.R. Inhibition of quercetin on liver fibrosis due to Schistosoma japonicum infection and on the expression of immediate early gene and metalloproteinase 1 inhibitor in liver tissue of mice. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, v.24, n.2, p.148-149, 2006.
90. YAMAGUCHI, Y.; SUDA, T.; SUDA J.; EGUCHI, M.; HARADA, N.; TOMINAGA, A.; TAKATSU, K. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med., v.167, n.1, p.43-56, 1988.
91. YING, B.; YANG, T.; SONG, X.; HU, X.; FAN, H.; LU, X.; CHEN, L.; CHENG, D.; WANG, T.; LIU, D.; XU, D.; WEI, Y.; WEN, F. Quercetin inhibits IL-1 beta-induced ICAM-1 expression in pulmonary epithelial cell line A549 through the MAPK pathways. Mol. Biol. Rep., v.36, n.6, p.1825-1832, 2009.
92. ZIMMERMANN, N.; HERSHEY, G.K.; FOSTER, P.S.; ROTHENBERG, M.E. Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin. Immunol., v.111, n.2, p.227-242, 2003.